Actively Recruiting

Age: 18Years +
All Genders
ID06484647

Comparing T-stenting And Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation Insights From TREX Registry

Led by San Luigi Gonzaga Hospital · Updated on 2024-07-08

382

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating two advanced stenting techniques, T-stenting And Minimal Protrusion (TAP) and External Minicrush, for treating complex coronary bifurcation in patients with coronary artery disease, including ischemic heart disease and acute or chronic coronary syndromes. These techniques are used when patients require percutaneous coronary intervention (PCI) at coronary bifurcation points, but differences in procedural, clinical, and safety outcomes between these methods remain unclear. The study builds on prior findings about related stenting methods and aims to clarify which technique may reduce complications like stent thrombosis and restenosis. Participants will undergo PCI following current coronary revascularization guidelines, with operators choosing vascular access and antiplatelet strategies based on patient characteristics. The TAP technique involves stenting the main vessel, rewiring to the side branch, and performing balloon inflations to open the side branch, followed by side branch stent implantation and final balloon inflations. The External Minicrush method includes side branch stent deployment with protrusion into the main vessel, crushing the side branch stent with a balloon, main vessel stenting, rewiring, and further balloon inflations including proximal optimization. Throughout the study, researchers will monitor participants over five years, focusing on outcomes such as target lesion failure, stent thrombosis, intrastent restenosis, and target vessel myocardial infarction. Participants will receive standard PCI care with follow-up assessments to evaluate the long-term safety and efficacy of the two stenting strategies. The overall goal is to improve treatment approaches for complex coronary bifurcation by understanding differences between these two techniques.

CONDITIONS

Brief Title

Comparing T-stenting And Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 18 years
  • Patients indicated for PCI, including chronic coronary syndrome and acute coronary syndromes (STEMI, NSTEMI, unstable angina)
  • Patients with at least one true coronary bifurcation according to the Medina classification (1.1.1, 0.1.1, 1.0.1, 0.0.1)
Not Eligible

You will not qualify if you...

  • Patients who do not want or cannot sign informed consent
  • Patients with severe peripheral vascular disease limiting vascular access
  • Patients with life expectancy less than 1 year
  • Patients planning major surgery requiring prolonged stopping of antiplatelet therapy
  • Pregnant women
  • Patients unable to take antiplatelet therapy for any reason

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Percutaneous Coronary Intervention

Duration - Procedure day

Participants undergo a percutaneous coronary intervention (PCI) using either the T-stenting And Minimal Protrusion or External Minicrush technique to treat complex coronary bifurcation.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants are monitored for up to 5 years to assess safety and efficacy outcomes including target lesion failure, stent thrombosis, and in-stent restenosis.

Follow-up visits as scheduled over 5 years

Trial Site Locations

Total: 1 location

1

Rivoli Hospital

Rivoli, Turin, Italy, 10098

Actively Recruiting

Loading map...

Research Team

G

Giulio Piedimonte, MD

E

Enrico Cerrato, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

Evaluating Myocardial Viability in Ischemic Heart Disease Us...

Ischemic Heart Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here